— Know what they know.
Not Investment Advice

AXRX OTC

Amexdrug Corporation
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -99.9% 5Y: -99.6%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 50 · $33882 mcap · 6M float · 0.0018% daily turnover

Balance Sheet Trends

Total Assets
$3M +1.5% ▲
5Y CAGR: +0.4%
Total Liabilities
$718K -0.4% ▼
5Y CAGR: -9.9%
Shareholders Equity
$2M +2.2% ▲
5Y CAGR: +7.3%
Cash & Investments
$2M +2.7% ▲
5Y CAGR: +30.0%
Total Debt
$431K -6.9% ▼
5Y CAGR: -13.5%
Net Debt
$384K -1.1% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2023FY2024FY2025
— Assets —
Cash$2M$735K$92K$75K$47K
Short-Term Investments$447K$853K$1M$2M$2M
Cash & ST Investments$2M$2M$1M$2M$2M
Net Receivables$240K$428K$575K$157K$152K
Inventory$1M$792K$477K$576K$530K
Other Current Assets$63K$63K$90K$90K$133K
Total Current Assets$4M$3M$2M$2M$3M
Property, Plant & Equip.$23K$23K$23K$23K$23K
Goodwill & Intangibles-$18K-$18K-$18K-$18K-$494
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0-$18K
Total Non-Current Assets$5K$5K$5K$5K$5K
Total Assets$4M$3M$2M$2M$3M
— Liabilities —
Accounts Payable$208K$411K$203K$252K$281K
Short-Term Debt$1M$0$1K$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$5K$3K$12K$4K$4K
Total Current Liabilities$1M$415K$216K$257K$287K
Long-Term Debt$934K$815K$490K$463K$431K
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$934K$815K$490K$463K$431K
Total Liabilities$2M$1M$707K$721K$718K
— Equity —
Common Stock$169K$169K$169K$169K$169K
Retained Earnings$1M$1M$2M$2M$2M
Accumulated OCI$192K$74K$36K$11K$40K
Total Stockholders Equity$2M$2M$2M$2M$2M
Total Liabilities & Equity$4M$3M$2M$2M$3M
— Key Metrics —
Total Debt$2M$815K$491K$463K$431K
Net Debt$420K$79K$399K$388K$384K
Total Investments$447K$853K$1M$2M$2M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms